Integrative genome-wide chromatin accessibility and transcriptome profiling of diffuse large B-cell lymphoma.
作者信息
Fang Ying, Zhang Mu-Chen, Xu Peng-Peng, Zhang Su-Jiang, Wang Li, Cheng Shu, Fu Di, Chang Chun-Kang, Sun Xiao-Jian, Zhao Yan, Tang Yi-Jia, Tian Xin, Yi Hong-Mei, Liu Feng, Zhao Wei-Li
机构信息
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Pathology, Shanghai Rui Jin Hospital; Shanghai Jiao Tong University School of Medicine, Shanghai, China.
出版信息
Clin Transl Med. 2022 Jul;12(7):e975. doi: 10.1002/ctm2.975.
Abstract
摘要
相似文献
1
Integrative genome-wide chromatin accessibility and transcriptome profiling of diffuse large B-cell lymphoma.
Clin Transl Med. 2022 Jul;12(7):e975. doi: 10.1002/ctm2.975.
2
Integrative genomic analysis of temozolomide resistance in diffuse large B-cell lymphoma.
Clin Cancer Res. 2014 Jan 15;20(2):382-92. doi: 10.1158/1078-0432.CCR-13-0669. Epub 2013 Oct 31.
3
Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma.
Acta Neuropathol. 2017 Feb;133(2):321-324. doi: 10.1007/s00401-016-1664-8. Epub 2017 Jan 5.
4
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Haematologica. 2013 Dec;98(12):1912-20. doi: 10.3324/haematol.2013.088740. Epub 2013 Jul 5.
5
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.
6
Long non-coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B-cell lymphoma.
Br J Haematol. 2023 Jul;202(2):440-444. doi: 10.1111/bjh.18870. Epub 2023 May 15.
7
Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications.
PLoS One. 2013 Apr 29;8(4):e61447. doi: 10.1371/journal.pone.0061447. Print 2013.
8
Diffuse large B-cell lymphoma: insights gained from gene expression profiling.
Int J Hematol. 2003 May;77(4):321-9. doi: 10.1007/BF02982638.
9
Re: the feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Cancer. 2007 Jun 25;111(3):200-1; author reply 201-2. doi: 10.1002/cncr.22693.
10
Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Mol Cancer. 2017 Jan 19;16(1):16. doi: 10.1186/s12943-017-0580-4.
引用本文的文献
1
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.
Clin Transl Med. 2024 Jun;14(6):e1691. doi: 10.1002/ctm2.1691.
本文引用的文献
1
Landscape of stimulation-responsive chromatin across diverse human immune cells.
Nat Genet. 2019 Oct;51(10):1494-1505. doi: 10.1038/s41588-019-0505-9. Epub 2019 Sep 30.
2
Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma.
Br J Haematol. 2019 Apr;185(1):79-88. doi: 10.1111/bjh.15757. Epub 2019 Jan 25.
3
Defining B Cell Chromatin: Lessons from EBF1.
Trends Genet. 2018 Apr;34(4):257-269. doi: 10.1016/j.tig.2017.12.014. Epub 2018 Jan 11.
4
ETV6 in hematopoiesis and leukemia predisposition.
Semin Hematol. 2017 Apr;54(2):98-104. doi: 10.1053/j.seminhematol.2017.04.005. Epub 2017 Apr 7.
5
Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.
Oncoimmunology. 2016 May 19;5(7):e1188246. doi: 10.1080/2162402X.2016.1188246. eCollection 2016 Jul.
6
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.
Nat Genet. 2016 Oct;48(10):1193-203. doi: 10.1038/ng.3646. Epub 2016 Aug 15.
7
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity.
Blood. 2015 Jan 1;125(1):22-32. doi: 10.1182/blood-2014-05-577189. Epub 2014 Dec 11.
8
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
J Clin Oncol. 2012 Oct 1;30(28):3452-9. doi: 10.1200/JCO.2011.41.0985. Epub 2012 Jul 30.
9
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.
Nat Rev Cancer. 2006 Jan;6(1):38-51. doi: 10.1038/nrc1779.
10
AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.
Exp Cell Res. 2005 Mar 10;304(1):175-86. doi: 10.1016/j.yexcr.2004.10.017. Epub 2004 Nov 18.
Zotero 插件